Check your eligibility now & get in touch with a study center

Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris

Acne vulgaris is a multifactorial, highly prevalent dermatologic condition that results in visible lesions that can be quite disfiguring. Consequently, individuals with acne often suffer from a wide range of psychological manifestations. Although there is consensus that combination therapy is most effective in treating acne, researchers are constantly striving to develop new treatment. Microcurrent therapy (MCT) is a non-invasive modality that has successfully been used to promote wound healing and has been routinely used in aesthetics. Use of MCT alone or in combination with current successful treatment such as blue light phototherapy (BLP), may hold promise for acne treatment

Am I eligible? Learn More

Detailed Description

The goal of this study is to conduct a small randomized control trial (RCT) to test the safety and preliminary efficacy of a novel combination therapy to treat acne vulgaris. The investigators will also explore the effects of the treatments on psychosocial factors (Dermatology Life Quality Index (DLQI), social anxiety, depressive symptomatology, and self-esteem). The RCT will have 3 arms: 1) FDA approved treatment: blue light phototherapy (BLP); 2) Microcurrent therapy (MCT); and 3) combination therapy (BLP + MCT). The main outcomes will be: 1) number of acne lesions; 2) amount of sebum produced, 3) degree of acne severity; and 4) improvement in dermatologic quality of life.

Simple Text Block

You can use content blocks to arrange your articles, large texts, instructions. Combine these blocks with media blocks to add illustrations and video tutorials. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links. You can use various content blocks to work with your text. Add quotations, lists, buttons. Select your text to change its formatting or add links.

Call 1800-9860-568 now to find out if you are eligible.

Find a site near you

Age

None - 100

Gender

Male

NCT ID

NCT67778

Phase

Status

Recruiting Now

Medical Condition

acne

How is Plaque Psoriasis treated?

Medical Condition

A short sentence to introduce what to expect in the about condition section

Learn more

The Study

A short sentence to introduce what to expect in the about condition section

Learn more

About Clinical Trials

A short sentence to introduce what to expect in the about condition section

Learn more

Your Journey

Receiving the medication

You would receive etanercept (Enbrel) twice a week for 12 weeks and then once a week for 12 weeks. Etanercept, as well as study related medical care, is provided at no cost.

Visiting the study site

Study participation involves approximately 8 visits to your local study center over 6 to 7 months.

Follow-up

There would also be a follow-up telephone call 30days after completing the study. No visits are required after participation is complete.